Centre François Baclesse
In research, Centre François Baclesse stands highest in Medicine (#4,506 of 10,443 worldwide) and Health Sciences (#6,096 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology — Oncology is 14.8× its share of world research.
- World rank, 2022–2025
- #16,473 of 28,054 · #16,776 all time
- Rank in France
- #723 of 1,422
- Research works
- 735 ▲ 24% vs 2013–17
- Citations
- 14k 19.4 per fractional work
- Top-10% rate
- 15.1% record average 16.5%
- Open access
- 28% world 28%
What is Centre François Baclesse known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #4,506 of 10,443 | 16.4% | 88 | #3991 | |
| Health SciencesDomain | #6,096 of 11,982 | 15.7% | 95 | #5470 |
Each strip is that field’s whole ranked pool, with the notch where Centre François Baclesse sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Centre François Baclesse specialise in?
Where its research is concentrated relative to its size: Oncology takes 14.8× the share of its output that it takes of world research.
- OncologySubfield · 20.7 works15×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.7×. Every wedge is a field page.
- Medicine 3.7×
- Health Professions 1.7×
- Biochemistry, Genetics and Molecular Biology 1.6×
- Veterinary 1.0×
- Physics and Astronomy 0.8×
- Dentistry 0.7×
- Neuroscience 0.6×
- Pharmacology, Toxicology and Pharmaceutics 0.5×
- Economics, Econometrics and Finance 0.5×
- Immunology and Microbiology 0.5×
- Environmental Science 0.4×
- Agricultural and Biological Sciences 0.3×
- Psychology 0.3×
- Mathematics 0.2×
- Chemistry 0.2×
- Computer Science 0.2×
- Engineering 0.1×
- Social Sciences 0.1×
- Nursing 0.1×
- Chemical Engineering 0.1×
- Arts and Humanities 0.1×
- Decision Sciences 0.1×
- Materials Science 0.1×
Who are the top researchers at Centre François Baclesse?
Ranked on the composite score, T. Delozier, Radj Gervais and Florence Joly lead among researchers whose main affiliation is Centre François Baclesse.
- 1 T. Delozier France · #88,525 worldwide 419 citations · 24 works
- 2 Radj Gervais France · #95,695 worldwide 298 citations · 24 works
- 3 Florence Joly France · #114,772 worldwide 162 citations · 34 works
- 4 D. De Raucourt France · #130,618 worldwide 485 citations · 20 works
- 5 Stéphane Bardet France · #158,457 worldwide 106 citations · 28 works
- 6 Christelle Lévy France · #304,899 worldwide 166 citations · 56 works
- 7 Florence Joly France · #417,757 worldwide 150 citations · 87 works
- 8 Corinne Delcambre France · #557,335 worldwide 63 citations · 22 works
- 9 E. Meyer France · #693,005 worldwide 22 citations · 29 works
- 10 Aurélien Corroyer‐Dulmont France · #712,068 worldwide 18 citations · 20 works
Which keywords describe research at Centre François Baclesse?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Radiotherapy, Breast Cancer, Quality of Life, Immunotherapy, Clinical Trials, Clinical Practice Guidelines and Survival Analysis.
- Dosimetry
- Genomic Analysis
- Squamous Cell Carcinoma
- Patient-Reported Outcomes
- Prognosis
- Ovarian Cancer
- Molecular Classification
- Cetuximab
- Health-related Quality of Life
- Anxiety
- Molecular Subtypes
- Cancer Survivorship
- Metastatic Breast Cancer
- Neoadjuvant Therapy
- Cancer
- Metastasis
- Survival Analysis
- Clinical Trials
- Breast Cancer
- Radiotherapy
- Chemotherapy
- Quality of Life
- Immunotherapy
- Clinical Practice Guidelines
- Biomarkers
- Targeted Therapy
- Prognostic Factors
- Precision Medicine
- Depression
- Genetic Mutations
- Tumor Microenvironment
- Cancer Therapy
- BRAF Mutation
- Prognostic Markers
- Genomic Profiling
- Survival
- Radiation Therapy
- Psychosocial Interventions
- Cytoreductive Surgery
- Cognitive Function
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy20▲ 23×23 topics
- Radiotherapy12▲ 25×12 topics
- Quality of Life10▲ 5.5×24 topics
- Breast Cancer9▲ 31×10 topics
- Immunotherapy8▲ 9.6×15 topics
- Clinical Trials8▲ 9.8×9 topics
- Clinical Practice Guidelines7▲ 11×11 topics
- Survival Analysis7▲ 19×6 topics
- Biomarkers6▲ 7.6×11 topics
- Metastasis6▲ 15×11 topics
- Targeted Therapy6▲ 21×5 topics
- Cancer6▲ 3.4×26 topics
- Prognostic Factors6▲ 10×14 topics
- Neoadjuvant Therapy5▲ 17×5 topics
- Precision Medicine5▲ 8.2×6 topics
- Metastatic Breast Cancer5▲ 66×2 topics
- Depression4▲ 4.0×9 topics
- Cancer Survivorship4▲ 46×2 topics
- Genetic Mutations4▲ 7.8×11 topics
- Molecular Subtypes4▲ 40×3 topics
- Tumor Microenvironment4▲ 7.3×6 topics
- Anxiety4▲ 6.7×7 topics
- Cancer Therapy4▲ 5.5×13 topics
- Health-related Quality of Life4▲ 14×3 topics
- BRAF Mutation4▲ 43×2 topics
- Cetuximab4▲ 37×2 topics
- Prognostic Markers4▲ 28×3 topics
- Molecular Classification4▲ 19×4 topics
- Genomic Profiling4▲ 28×2 topics
- Ovarian Cancer4▲ 32×3 topics
- Survival4▲ 21×4 topics
- Prognosis3▲ 8.4×7 topics
- Radiation Therapy3▲ 20×5 topics
- Patient-Reported Outcomes3▲ 48×1 topic
- Psychosocial Interventions3▲ 48×1 topic
- Squamous Cell Carcinoma3▲ 29×3 topics
- Cytoreductive Surgery3▲ 39×2 topics
- Genomic Analysis3▲ 10×4 topics
- Cognitive Function3▲ 13×4 topics
- Dosimetry3▲ 34×2 topics
Which research topics does Centre François Baclesse publish most on?
By volume in 2022–2025: Cancer survivorship and care, Advanced Breast Cancer Therapies, Breast Cancer Treatment Studies and Ovarian cancer diagnosis and treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer survivorship and care Oncology 3 works
- 2 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 3 works
- 3 Breast Cancer Treatment Studies Cancer Research 3 works
- 4 Ovarian cancer diagnosis and treatment Reproductive Medicine 3 works
- 5 Cancer Immunotherapy and Biomarkers Oncology 2 works
- 6 Head and Neck Cancer Studies Otorhinolaryngology 2 works
- 7 Thyroid Cancer Diagnosis and Treatment Endocrinology, Diabetes and Metabolism 2 works
- 8 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
- 9 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 2 works
- 10 Cancer Treatment and Pharmacology Oncology 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Centre François Baclesse's research output changed?
Output in 2018–2022 was 24% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Caen
- Université de Caen Normandie
- Normandie Université
- Centre Hospitalier Universitaire de Caen Normandie
- Laboratoire de Cristallographie et Sciences des Matériaux
- École Nationale Supérieure d'Ingénieurs de Caen
- Grand Accélérateur National d'Ions Lourds
- GREYC
- Laboratoire de Physique Corpusculaire de Caen
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.